Walleye Capital
PTCT icon

Walleye Capital’s PTC Therapeutics PTCT Stock Holding History

Walleye Capital’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
+19,522
New +$1.41M 0.01% 1722
2026
Q1 		– Sell
-18,074
Closed -$1.37M – 4862
2025
Q4 		$1.37M Buy
18,074
+6,731
+59% +$489K ﹤0.01% 2180
2025
Q3 		$696K Sell
11,343
-26,564
-70% -$1.38M ﹤0.01% 2359
2025
Q2 		$1.85M Sell
37,907
-31,253
-45% -$1.48M 0.01% 1576
2025
Q1 		$3.52M Sell
69,160
-40,844
-37% -$2.04M 0.02% 1019
2024
Q4 		$4.97M Buy
+110,004
New +$4.71M 0.01% 1076
2024
Q3 		– Sell
-85,147
Closed -$2.6M – 5753
2024
Q2 		$2.6M Buy
85,147
+73,484
+630% +$2.38M ﹤0.01% 1864
2024
Q1 		$339K Buy
+11,663
New +$327K ﹤0.01% 3542
2023
Q4 		– Sell
-72,030
Closed -$1.61M – 5398
2023
Q3 		$1.61M Buy
72,030
+65,226
+959% +$2.43M ﹤0.01% 1894
2023
Q2 		$277K Sell
6,804
-76,942
-92% -$3.76M ﹤0.01% 2860
2023
Q1 		$4.06M Sell
83,746
-11,485
-12% -$525K 0.06% 395
2022
Q4 		$3.63M Buy
+95,231
New +$3.96M 0.07% 354
2022
Q3 		– Sell
-60,412
Closed -$2.42M – 3470
2022
Q2 		$2.42M Buy
60,412
+50,379
+502% +$1.77M 0.07% 310
2022
Q1 		$374K Buy
+10,033
New +$387K 0.01% 1174
2020
Q1 		– Sell
-1,500
Closed -$72K – 1506
2019
Q4 		$72K Buy
+1,500
New +$63.7K ﹤0.01% 1436
2019
Q3 		– Sell
-1,294
Closed -$56.3K – 2183
2019
Q2 		$58K Buy
+1,294
New +$51.1K 0.01% 1353

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Walleye Capital's PTCT Position: Q2 2026 in Review

Walleye Capital opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 19,522 shares worth $1.59M. The stake represents 0.01% of the portfolio and ranks #1722 among its holdings. This is a return to the name: Walleye Capital previously reported a position in PTCT as recently as Q4 2025.

Walleye Capital first reported a position in PTCT in Q2 2019 and has held it in 16 quarters since. The position peaked at $4.97M in Q4 2024. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Walleye Capital held 19,522 shares of PTC Therapeutics worth $1.59M as of Q2 2026.
  • PTC Therapeutics was a new Walleye Capital position in Q2 2026.
  • PTC Therapeutics made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1722 holding.
  • Walleye Capital first reported a position in PTC Therapeutics in Q2 2019 and has held it in 16 quarters since.
  • Walleye Capital's PTC Therapeutics position peaked at $4.97M in Q4 2024.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.